BioWatch: Cell Therapeutics Versus FDA, Before ASCO (CTICD)
Cell Therapeutics, Inc. (NASDAQ: CTICD) has been very active since its recent 1-for-6 reverse stock split took place on May 16, 2011. Its share volume has increased on all but ...Read Full Story »













